Sarepta Therapeutics, Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Sarepta Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2010 to Q3 2024.
  • Sarepta Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $11.8M.
  • Sarepta Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $48.4M.
  • Sarepta Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was -$252M, a 64.1% decline from 2022.
  • Sarepta Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$154M, a 477% decline from 2021.
  • Sarepta Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was $40.8M, a 267% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $48.4M $11.8M +$24.1M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $24.2M $14.3M -$105M -88% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $129M $6.54M +$381M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 -$252M $15.7M +$10.2M +185% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 -$262M -$12.3M +$113M +90.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 -$375M $119M +$136M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$511M -$375M -$357M -2070% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 -$154M $5.53M +$21.6M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$175M -$125M -$112M -830% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 -$63.8M -$17M -$103M -120% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $39M -$17.3M -$1.74M -11.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $40.8M -$16.1M +$1.69M +9.53% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $39.1M -$13.4M +$45.9M +77.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 -$6.82M $85.8M +$98.3M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 -$105M -$15.5M -$116M -115% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $11.1M -$17.8M -$13M -272% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-01
Q3 2020 $24.1M -$59.3M -$56.8M -2264% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $80.9M -$12.4M -$11.6M -1344% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $92.5M $101M +$101M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$8.32M -$4.77M -$2.46M -107% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 -$5.86M -$2.51M +$4.46M +64% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-01
Q2 2019 -$10.3M -$862K +$4.36M +83.5% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-01
Q1 2019 -$14.7M -$172K +$4.31M +96.2% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-01
Q4 2018 -$19M -$2.31M +$382K +14.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-26
Q3 2018 -$19.4M -$6.97M -$7.15M -3887% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-26
Q2 2018 -$12.2M -$5.22M -$5.4M -2936% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-26
Q1 2018 -$6.81M -$4.49M -$130M -104% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-26
Q4 2017 $123M -$2.69M -$2.64M -4625% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-28
Q3 2017 $126M $184K +$393K Jul 1, 2017 Sep 30, 2017 10-K 2019-02-28
Q2 2017 $125M $184K +$385K Apr 1, 2017 Jun 30, 2017 10-K 2019-02-28
Q1 2017 $125M $125M +$125M Jan 1, 2017 Mar 31, 2017 10-K 2019-02-28
Q4 2016 -$535K -$57K +$172K +75.1% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 -$707K -$209K -$33K -18.8% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-01
Q2 2016 -$674K -$201K -$457K -179% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-01
Q1 2016 -$217K -$68K -$371K -122% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-01
Q4 2015 $154K -$229K -$535K -175% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-28
Q3 2015 $689K -$176K -$4.63M -104% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-28
Q2 2015 $5.31M $256K +$3.86M Apr 1, 2015 Jun 30, 2015 10-K 2017-02-28
Q1 2015 $1.46M $303K +$3.46M Jan 1, 2015 Mar 31, 2015 10-K 2017-02-28
Q4 2014 -$2M $306K -$23.7M -98.7% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-25
Q3 2014 $21.7M $4.45M +$21.5M Jul 1, 2014 Sep 30, 2014 10-K 2016-02-25
Q2 2014 $177K -$3.6M -$1.64M -83.5% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-25
Q1 2014 $1.82M -$3.15M +$23.5M +88.2% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-25
Q4 2013 -$21.7M $24M +$75.7M Oct 1, 2013 Dec 31, 2013 10-K 2015-02-26
Q3 2013 -$97.4M -$17.1M +$25.6M +59.9% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-26
Q2 2013 -$123M -$1.96M -$15.6M -114% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-26
Q1 2013 -$107M -$26.7M -$15.8M -146% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-26
Q4 2012 -$91.6M -$51.7M -$59.3M -781% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-26
Q3 2012 -$32.3M -$42.6M -$49.9M -688% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $17.6M $13.6M +$2.19M +19.2% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 $15.4M -$10.8M -$18.2M -247% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 $33.6M $7.59M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-03
Q3 2011 $7.25M +$10.7M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-07
Q2 2011 $11.4M +$20.4M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 $7.36M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q3 2010 -$3.5M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-08
Q2 2010 -$8.99M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.